A Search Service for Abbreviation / Long Form

â–  Abbreviation / Long Form : iPS / induced pluripotent stem

[Related PubMed/MEDLINE]
Total Number of Papers: 1713
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   iPS  (>> Co-occurring Abbreviation)
Long Form:   induced pluripotent stem
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Establishment of a novel culture method for maintaining intestinal stem cells derived from human induced pluripotent stem cells. ISCs
2020 Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity. iPS-CMs, iPS-EC
2020 Hypothalamic Contribution to Pituitary Functions Is Recapitulated InVitro Using 3D-Cultured Human iPS Cells. ACTH, CRH, ESCs
2020 p53 controls genomic stability and temporal differentiation of human neural stem cells and affects neural organization in human brain organoids. KD, NES, OXPHOS
2020 Reprogramming of Primary Human Cells to Induced Pluripotent Stem Cells Using Sendai Virus. ---
2020 Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming. ES
2020 Smad1/5 signal transduction regulates the ameloblastic differentiation of induced pluripotent stem cells. ALK, ASF-CM, BMPR-II, BMPs, MAPKs
2020 The long-noncoding RNA MALAT1 regulates TGF-beta/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells. lncRNAs
2020 The novel application of cordycepin in maintaining stem cell pluripotency and increasing iPS cell generation efficiency. CNTF, ECM, EGF, ES, MEFs, OSM
10  2020 Tolloid-Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling. TGF-beta, TLL1
11  2020 [Current Therapies for Amyotrophic Lateral Sclerosis in Japan]. ALS
12  2019 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro. ---
13  2019 A novel machine learning based approach for iPS progenitor cell identification. MEFs
14  2019 A preliminary study on the mechanism of skeletal abnormalities in Turner syndrome using inducing pluripotent stem cells (iPS)- based disease models. EBs, TRAP, TS
15  2019 Abnormal nuclear aggregation and myotube degeneration in myotonic dystrophy type 1. 3'-UTR, DMPK
16  2019 Acid stimulation-induced semi-pluripotent characteristics in human somatic cells. AKP
17  2019 Addiction associated N40D mu-opioid receptor variant modulates synaptic function in human neurons. iNs, sIPSCs
18  2019 Adult and iPS-derived non-parenchymal cells regulate liver organoid development through differential modulation of Wnt and TGF-beta. ---
19  2019 Airway regeneration using iPS cell-derived airway epithelial cells with Cl- channel function. CF
20  2019 Analysis of the mechanism underlying liver diseases using human induced pluripotent stem cells. ---
21  2019 Application of pluripotent stem cells for treatment of human neuroendocrine disorders. ES
22  2019 Approach to Neurotoxicity using Human iPSC Neurons: Consortium for Safety Assessment using Human iPS Cells. JPMA, MEA
23  2019 Arrhythmogenicity Test Based on a Human-Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocyte Layer. hiPSC-CMs, iPSC
24  2019 Automated quantification study of human cardiomyocyte synchronization using holographic imaging. ---
25  2019 Cell biological profiling of reprogrammed cancer stem cell-like colon cancer cells maintained in culture. CSCs
26  2019 Cell sheet tissue engineering: Cell sheet preparation, harvesting/manipulation, and transplantation. ECMs, PIPAAm, TCPS
27  2019 Cell therapy for central nervous system disorders: Current obstacles to progress. ---
28  2019 Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives. ES
29  2019 Compartmentalized Devices as Tools for Investigation of Human Brain Network Dynamics. ---
30  2019 Culture System of Bile Duct-Like Cystic Structures Derived from Human-Inducible Pluripotent Stem Cells. ---
31  2019 Cytoplasmic fusion between an enlarged embryonic stem cell and a somatic cell using a microtunnel device. DC, ES
32  2019 Deconstructing age reprogramming. NT-ES
33  2019 Disassembling and Reaggregating the Thymus: The Pros and Cons of Current Assays. ES, FTOC, MHC, RTOC
34  2019 Disease Modeling of Neuropsychiatric Brain Disorders Using Human Stem Cell-Based Neural Models. AD, ASD, ES, NPCs, PS
35  2019 DNA methylation patterns in human iPSC-derived sensory neuronal differentiation. ---
36  2019 Drug discovery in psychopharmacology: from 2D models to cerebral organoids
. ---
37  2019 Effect of EDTA-treated dentin on the differentiation of mouse iPS cells into osteogenic/odontogenic lineages in vitro and in vivo. EBs, ICF, SEM
38  2019 Effect of heat stress on blood-brain barrier integrity in iPS cell-derived microvascular endothelial cell models. BBB, P-gp, TEER
39  2019 Effects of reprogramming on genomic imprinting and the application of pluripotent stem cells. ICRs, ntES
40  2019 Enhanced Function of Induced Pluripotent Stem Cell-Derived Endothelial Cells Through ESM1 Signaling. CX40, ESM1
41  2019 Expansion and differentiation of human iPS cells in a three-dimensional culture using hollow fibers and separation of the specific population by magnetic-activated cell sorting. HFs
42  2019 Extra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A. EVOO, LSD1, SOX2
43  2019 Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine. AMD, RPE
44  2019 FGF signal is not required for hepatoblast differentiation of human iPS cells. BMPs, FGFs
45  2019 Functional Scaffolding for Brain Implants: Engineered Neuronal Network by Microfabrication and iPSC Technology. ---
46  2019 Functional Screening Identifies MicroRNA Regulators of Corin Activity and Atrial Natriuretic Peptide Biogenesis. 3'UTR, Ago2, ANP, miR-1-3p, miRNAs
47  2019 Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction. CDX2, iPS-IECM, ZO-1
48  2019 Generation of Mouse-Induced Pluripotent Stem Cells by Lentiviral Transduction. Dox, MEFs
49  2019 Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system. DEGs, PC, PS
50  2019 Generation of Stable Induced Pluripotent Stem-like Cells from Adult Zebra Fish Fibroblasts. ziPSCs
51  2019 Genome imprinting in stem cells: A mini-review. ES
52  2019 Global transcriptome analysis of pig induced pluripotent stem cells derived from six and four reprogramming factors. ---
53  2019 Glucose-Responsiveness of Pancreatic beta-Like (GRP beta-L) Cells Generated from Human Pluripotent Stem Cells. GRP beta-L, GRPbeta-L, T1D
54  2019 Graft immaturity and safety concerns in transplanted human kidney organoids. ---
55  2019 Hair-Follicle-Associated Pluripotent (HAP) Stem Cells Encapsulated on Polyvinylidene Fluoride Membranes (PFM) Promote Functional Recovery from Spinal Cord Injury. BMS, ES, GFP, HAP, PFM
56  2019 HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models. HBV, HCC
57  2019 Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing. ---
58  2019 Highly efficient induction of primate iPS cells by combining RNA transfection and chemical compounds. ---
59  2019 Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis. CNS
60  2019 Human Pluripotent Stem Cells (iPSC) Generation, Culture, and Differentiation to Lung Progenitor Cells. ES
61  2019 Improved methods for the differentiation of hypothalamic vasopressin neurons using mouse induced pluripotent stem cells. ---
62  2019 In vitro establishment of expanded-potential stem cells from mouse pre-implantation embryos or embryonic stem cells. EPI, EPSCs, ES, PrE, TE, TS
63  2019 Induced pluripotent stem cell-derived endothelial cells attenuate lipopolysaccharide-induced acute lung injury. EC, LPS
64  2019 Isolation of induced pluripotent stem cell-derived endothelial progenitor cells from sac-like structures. AcLDL, EPCs, GSK3beta, iPS-sacs
65  2019 LIM homeobox 2 promotes interaction between human iPS-derived hepatic progenitors and iPS-derived hepatic stellate-like cells. iPS-HPCs, iPS-HSCs, LHX2
66  2019 Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium. CCs, CHF, CTGF, IL-8, PKHD1-KO
67  2019 LRRK2 modifies alpha-syn pathology and spread in mouse models and human neurons. PD, PFF, SNpc
68  2019 mRNA and miRNA expression profiles in an ectoderm-biased substate of human pluripotent stem cells. ES
69  2019 Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming. ---
70  2019 Neural differentiation of mouse induced pluripotent stem cells using cadherin gene-engineered PA6 feeder cells. SDIA
71  2019 Neuronal network dysfunction in a model for Kleefstra syndrome mediated by enhanced NMDAR signaling. KS, NMDAR
72  2019 Novel neuromuscular junction model in 2D and 3D myotubes co-cultured with induced pluripotent stem cell-derived motor neurons. ---
73  2019 Nuclear transplantation between allogeneic cells through topological reconnection of plasma membrane in a microfluidic system. ---
74  2019 Organ Generation from Knockedout Rat Blastocysts Complemented with Pluripotent Stem Cells. ES, KO
75  2019 Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease. MELAS, OXPHOS, ROS
76  2019 Pharmaceutical Research for Inherited Metabolic Disorders of the Liver Using Human Induced Pluripotent Stem Cell and Genome Editing Technologies. ---
77  2019 Potential therapeutic effects of induced pluripotent stem cells on induced salivary gland cancer in experimental rats. PBS, SCC
78  2019 Precise therapeutic gene correction by a simple nuclease-induced double-stranded break. HPS1, LbCas12a, LGMD2G, MMEJ, PARP-1, SpCas9
79  2019 Production of Transgenic Porcine Embryos Reconstructed with Induced Pluripotent Stem-Like Cells Derived from Porcine Endogenous Factors Using piggyBac System. PB, SCNT
80  2019 Propagation and Purification of Human Induced Pluripotent Stem Cells with Selective Homopolymer Release Surfaces. PDEGMA
81  2019 Regeneration of a bioengineered 3D integumentary organ system from iPS cells. 3D-IOS, CDB, EBs
82  2019 Scalable Measurements of Intrinsic Excitability in Human iPS Cell-Derived Excitatory Neurons Using All-Optical Electrophysiology. APs
83  2019 SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets. LUBAC, sCD40L
84  2019 Single-cell study of neural stem cells derived from human iPSCs reveals distinct progenitor populations with neurogenic and gliogenic potential. NSC, Seq
85  2019 Sustained and regulated gene expression by Tet-inducible "all-in-one" retroviral vectors containing the HNRPA2B1-CBX3 UCOE. UCOE's
86  2019 The Construction of Retinal Pigment Epithelium Sheets with Enhanced Characteristics and Cilium Assembly Using iPS Conditioned Medium and Small Incision Lenticule Extraction Derived Lenticules. DMEM, EMT, FLI-lenticule, IGFBP, PDGF-AA, qPCR, RPE, TCP, TER, TGF, UVC
87  2019 Thermally-triggered fabrication of cell sheets for tissue engineering and regenerative medicine. ---
88  2019 Topography enhances Runx2 expression in outgrowing cells from iPS cell-derived embryoid bodies. EBs, ICF, OGCs, qRT-PCR, SEM
89  2019 Transposon mediated reprogramming of buffalo fetal fibroblasts to induced pluripotent stem cells in feeder free culture conditions. PB
90  2019 Using human stem cells as a model system to understand the neural mechanisms of alcohol use disorders: Current status and outlook. AUDs, SNP, US
91  2019 [A Culture System Similar to the Embryonal Microenvironment Supports Transdifferentiation in Human Leiomyoma Cells]. ---
92  2019 [Experimental study on the effect of acid stimulation on human cell characteristics]. AKP
93  2019 [Generation of human iPS cell-derived hepatocytes and enterocytes for application to drug disposition studies]. ---
94  2019 [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity]. CM
95  2019 [In vitro study of bone morphogenetic protein 2 gelatin/chitosan hydrogel sustained-release system composite hydroxyapatite/zirconium dioxide foam ceramics and induced pluripotent stem cells derived mesenchymal stem cells]. BMP-2, Cbfa1, HA, MSCs, Osx
96  2019 [Mass-Production of Tumor Antigen-Specific Cytotoxic T Lymphocytes Using the iPS Cell Technology-Development of "Off-the-Shelf T Cells"for the Use in Allogeneic Transfusion Settings]. TCR
97  2019 [Pharmaceutical Research on Liver Diseases Using iPS Cell and Genome Editing Technologies]. ---
98  2018 A new genetic tool to improve immune-compromised mouse models: Derivation and CRISPR/Cas9-mediated targeting of NRG embryonic stem cell lines. ES, ESC, NOD
99  2018 Age reprogramming and epigenetic rejuvenation. eAge, NT-ES
100  2018 Allele-Specific Biased Expression of the CNTN6 Gene in iPS Cell-Derived Neurons from a Patient with Intellectual Disability and 3p26.3 Microduplication Involving the CNTN6 Gene. CNVs